Jazz completes ex-U.S. divestiture of Sunosi to Axsome

Jazz Pharmaceuticals plc

Completed ex-U.S. divestiture of Sunosi (solriamfetol) to Axsome Therapeutics on November 14, 2022.
Earlier U.S. divestiture of Sunosi completed on May 9, 2022.
Original deal announced on March 28, 2022; global divestiture now fully completed.

item 8.01

Jazz Pharmaceuticals plc filing history →

Source: SEC EDGAR

accession 0001193125-22-284671

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.